LFVN Lifevantage

IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of LifeVantage Corporation and Reminds Investors with Losses to Contact the Firm

Khang & Khang LLP (the “Firm”) announces that it is investigating claims against LifeVantage Corporation (“LifeVantage” or the “Company”) (Nasdaq: LFVN) concerning possible violations of federal securities laws.

If you purchased shares of LifeVantage and want more information, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by e-mail at [email protected].

The investigation focuses on the Company’s announcement on September 13, 2016 that it would delay the release of its fourth quarter and fiscal year 2016 financial results. The reason for the delay is for LifeVantage to carry out an internal review of sales into certain international markets and the revenue and income tax associated with those sales. The Company stated that it is unable to estimate the impact of the review to net revenue, tax expense, net income or other aspects of its financial statements for the fiscal year ended June 30, 2016 or any potential prior periods. When this news was announced, shares of LifeVantage decreased in value.

If you have any questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by e-mail at [email protected].

This press release may constitute Attorney Advertising in some jurisdictions.

EN
14/09/2016

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Lifevantage

 PRESS RELEASE

LifeVantage Declares Quarterly Dividend

LifeVantage Declares Quarterly Dividend SALT LAKE CITY, May 06, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company’s Board of Directors has approved a quarterly cash dividend of $0.045 per share of common stock, which will be paid June 13, 2025 to all stockholders of record at the close of business on May 30, 2025. This represents an increase in the dividend amount by 12.5% over the previous quarter. About LifeVantage Corpo...

 PRESS RELEASE

LifeVantage Announces Financial Results for the Third Quarter of Fisca...

LifeVantage Announces Financial Results for the Third Quarter of Fiscal 2025 SALT LAKE CITY, May 06, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its third fiscal quarter ended March 31, 2025. Third Quarter Fiscal 2025 Summary*: Revenue was $58.4 million, an increase of 21.1% from the prior year period. Excluding the negative impact of foreign currency fluctuations, third quarter revenue increased approximat...

 PRESS RELEASE

Global Convention 2025 Empowers Consultants to ‘Go Further’ with Exclu...

Global Convention 2025 Empowers Consultants to ‘Go Further’ with Exclusive Trainings, Product Announcements, and New Incentives to Drive Growth Convention hosted in Salt Lake City, Utah April 24-26, attended by over 2,000 Independent Consultants from around the world SALT LAKE CITY, April 28, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced the successful conclusion of their annual Global Convention, held April 24-26, 2025, in Salt Lake City, Utah. Thousands ...

 PRESS RELEASE

LifeVantage to Announce Third Quarter Fiscal Year 2025 Results on May ...

LifeVantage to Announce Third Quarter Fiscal Year 2025 Results on May 6, 2025 SALT LAKE CITY, April 22, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results for its third quarter ended March 31, 2025, after the stock market closes on Tuesday, May 6, 2025. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day. Investors interested in partici...

 PRESS RELEASE

LifeVantage Expands Global Reach with International Launch of the MB S...

LifeVantage Expands Global Reach with International Launch of the MB System™ Following the highly successful launch in U.S. market, LifeVantage begins taking its groundbreaking MB System™ internationally SALT LAKE CITY, March 17, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, is extending its groundbreaking MindBody GLP-1 System™ to international markets. This expansion comes after a 49% year-over-year increase in fiscal Q2 revenue ending December 31, 2024, in the U.S., la...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch